Literature DB >> 21883378

Cell biology of Smad2/3 linker region phosphorylation in vascular smooth muscle.

Hossein B Rezaei1, Danielle Kamato, Ghazaleh Ansari, Narin Osman, Peter J Little.   

Abstract

The transforming growth factor (TGF)-β superfamily of ligands regulates a diverse set of cellular functions. Transforming growth factor-β induces its biological effects through Type I and Type II transmembrane receptors that have serine/threonine kinase activities and weak tyrosine kinase activity. In vascular smooth muscle, TGF-β binds to the TGF-β Type II receptor (TβRII) at the cell surface, recruiting the Type I receptor (TβRI) to form a heterocomplex. Consequently, after phosphorylation and activation of TβRI, the transcription factors receptor activated (R-) Smad2 and Smad3 are recruited and activated through phosphorylation of C terminal residues. Overall, Smad2/3 and co-Smad4 have similar structures consisting of three regions an N-terminal MH1 domain, a C-terminal MH2 domain and a central linker region. Phosphorylation of the Smad linker region appears to have an important role in the regulation of Smad activity and function. The mitogen-activated protein kinase (MAPK) family, CDK2, CDK4 and calcium-calmodulin dependent kinase are the main kinases that phosphorylate sites in the linker region. The role of the linker region includes enabling the formation of Smad homo-oligomers and provision of phosphorylation sites for MAPK and other kinases. In some instances, linker region phosphorylation regulates the inhibition of the nuclear translocation of Smads. In the present review, we describe TGF-β signalling through Smad2/3 and the importance of the linker region in the regulation and expression of genes induced by TGF-β superfamily ligands in the context of vascular smooth muscle.
© 2011 The Authors. Clinical and Experimental Pharmacology and Physiology © 2011 Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21883378     DOI: 10.1111/j.1440-1681.2011.05592.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  17 in total

1.  Identification and characterization of functional Smad8 and Smad4 homologues from Echinococcus granulosus.

Authors:  Chuanshan Zhang; Limin Wang; Hui Wang; Hongwei Pu; Le Yang; Jing Li; Junhua Wang; Guodong Lü; Xiaomei Lu; Wenbao Zhang; Dominique A Vuitton; Hao Wen; Renyong Lin
Journal:  Parasitol Res       Date:  2014-07-20       Impact factor: 2.289

2.  Toll-like Receptor 4 Stimulates Gene Expression via Smad2 Linker Region Phosphorylation in Vascular Smooth Muscle Cells.

Authors:  Rizwana Afroz; Ying Zhou; Peter J Little; Suowen Xu; Raafat Mohamed; Jennifer Stow; Danielle Kamato
Journal:  ACS Pharmacol Transl Sci       Date:  2020-03-11

3.  Smad3 deficiency protects mice from obesity-induced podocyte injury that precedes insulin resistance.

Authors:  Yu B Y Sun; Xinli Qu; Victor Howard; Lie Dai; Xiaoyun Jiang; Yi Ren; Ping Fu; Victor G Puelles; David J Nikolic-Paterson; Georgina Caruana; John F Bertram; Mark W Sleeman; Jinhua Li
Journal:  Kidney Int       Date:  2015-05-06       Impact factor: 10.612

Review 4.  The expansion of GPCR transactivation-dependent signalling to include serine/threonine kinase receptors represents a new cell signalling frontier.

Authors:  Danielle Kamato; Muhamad Ashraf Rostam; Rebekah Bernard; Terrence J Piva; Nitin Mantri; Daniel Guidone; Wenhua Zheng; Narin Osman; Peter J Little
Journal:  Cell Mol Life Sci       Date:  2014-11-12       Impact factor: 9.261

5.  Signal transduction in cerebral arteries after subarachnoid hemorrhage-a phosphoproteomic approach.

Authors:  Benjamin L Parker; Martin Røssel Larsen; Lars I H Edvinsson; Gro Klitgaard Povlsen
Journal:  J Cereb Blood Flow Metab       Date:  2013-05-29       Impact factor: 6.200

6.  Endothelial dysfunction exacerbates renal interstitial fibrosis through enhancing fibroblast Smad3 linker phosphorylation in the mouse obstructed kidney.

Authors:  Yu Bo Yang Sun; Xinli Qu; Xueling Li; David J Nikolic-Paterson; Jinhua Li
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

7.  MiR-1 suppresses tumor cell proliferation in colorectal cancer by inhibition of Smad3-mediated tumor glycolysis.

Authors:  Wanfu Xu; Zijing Zhang; Kejian Zou; Yang Cheng; Min Yang; Huan Chen; Hongli Wang; Junhong Zhao; Peiyu Chen; Liying He; Xinwen Chen; Lanlan Geng; Sitang Gong
Journal:  Cell Death Dis       Date:  2017-05-04       Impact factor: 8.469

Review 8.  The BMP Pathway in Blood Vessel and Lymphatic Vessel Biology.

Authors:  Ljuba C Ponomarev; Jakub Ksiazkiewicz; Michael W Staring; Aernout Luttun; An Zwijsen
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923

9.  Multiple Growth Factors, But Not VEGF, Stimulate Glycosaminoglycan Hyperelongation in Retinal Choroidal Endothelial Cells.

Authors:  Othman Al Gwairi; Narin Osman; Robel Getachew; Wenhua Zheng; X-L Liang; Danielle Kamato; Lyna Thach; Peter J Little
Journal:  Int J Biol Sci       Date:  2016-07-18       Impact factor: 6.580

Review 10.  The Molecular Genetics of Marfan Syndrome.

Authors:  Qiu Du; Dingding Zhang; Yue Zhuang; Qiongrong Xia; Taishen Wen; Haiping Jia
Journal:  Int J Med Sci       Date:  2021-05-27       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.